Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses
Hiroshi Ishii, Takushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, Trang Thi Thu Hau, Shigeyoshi Harada, Sayuri Seki, Midori Nakamura‐Hoshi, Midori Okazaki, Sachie Daigen, Ai Kawana‐Tachikawa, Noriyo Nagata, Naoko Iwata‐Yoshikawa, Nozomi Shiwa, Tadaki Suzuki, Eun‐Sil Park, Ken Maeda, Taishi Onodera, Yoshimasa Takahashi, Kohji Kusano, Ryutaro Shimazaki, Yuriko Suzaki, Yasushi Ami, Tetsuro Matano
Abstract
T cell responses to contribute to COVID-19 containment.
Topics & Concepts
Nasal administrationVirologyVaccinationMedicineImmunologyAntibodyCoronavirusAntigenCD8Neutralizing antibodyPandemicT cellImmune systemCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)Internal medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing